Streetbeat News

VEXTF

Vext Science Inc.

https://www.vapenmj.com/

Industry

Medicinal and Botanical Manufacturing

Open

0.11

Mkt cap

30M

Volume

49K

High

0.12

P/E Ratio

4.00

52-wk high

0.27

Low

0.11

Div yield

N/A

52-wk low

0.09

Vext Science, Inc. reported an 8% YoY revenue drop in Q2 2024, but anticipates growth from Ohio's new recreational cannabis market. Despite financial setbacks, Vext is optimistic about its Ohio operations and future performance.

Portfolio Pulse from Jelena Martinovic

August 20, 2024 | 1:27 pm

Vext Science, Auxly Cannabis Group, and MediPharm Labs are set to release their Q2 2024 financial results in mid-August. Vext Science is highlighted for its significant growth potential, especially in the Ohio market. Auxly has shown record-breaking Q1 results and significant debt conversion into equity. MediPharm has entered a licensing agreement for advanced cannabis products and reported a 67% revenue increase in Q1 2024.

Portfolio Pulse from Jelena Martinovic

August 09, 2024 | 3:37 pm

As Ohio begins recreational cannabis sales on August 6, Pablo Zuanic of Zuanic & Associates has initiated coverage of Vext Science (OTC:VEXTF) with an Overweight rating, citing significant growth potential. Zuanic projects Vext's EBITDA could grow six-fold by CY26. The Ohio market is expected to reach $2.36 billion by 2026. Despite trading in line with the MSO average, Vext's stock valuation does not yet reflect the expected EBITDA ramp. Other MSOs mentioned include Acreage (OTCQX:ACRHF), Cannabist (CSE:CCHW), Ascend (OTC:AAWH), Cresco (OTC:CRLBF), Green Thumb (OTCQX:GTBIF), and MariMed (OTCQB:MRMD).

Portfolio Pulse from Nicolás Jose Rodriguez

August 05, 2024 | 11:52 pm

Several cannabis companies are approaching significant debt maturities, which could impact their financial stability and investor portfolios. Curaleaf, Cresco Labs, Green Thumb, and Ascend Wellness face substantial refinancing risks, while Vext Science, Jushi Holdings, and Cansortium have relatively moderate debt challenges. Investors should monitor these developments closely.

Portfolio Pulse from Nicolás Jose Rodriguez

June 25, 2024 | 10:34 pm

The Viridian Chart of the Week analyzes the relationship between financial strength and YTD stock performance of 30 MSO/SSOs. Group 1, consisting of the strongest companies, has shown significant gains, while weaker groups have underperformed. Investors are advised to focus on stronger companies like Verano, Trulieve, and Cresco, with potential targeted investments in lower strength companies with positive catalysts.

Portfolio Pulse from Viridian Capital Advisors

June 24, 2024 | 5:12 pm

Senior analyst Pablo Zuanic projects significant growth in Ohio's cannabis market as it transitions to adult-use recreational sales by July 2024. The market could grow fourfold within a year, reaching $2.3 billion. Publicly traded multi-state operators (MSOs) like Vext, Acreage, Cannabist, and Ascend are identified as having high potential for market cap gains.

Portfolio Pulse from Nicolás Jose Rodriguez

May 30, 2024 | 7:07 pm

Vext Science, Inc. reported a year-over-year decline in Q1 2024 revenue and net income, but announced a $2 million standby credit facility to support its expansion in Ohio's upcoming recreational marijuana market. Despite the decline, Vext's shares rose 5.08% after the market close.

Portfolio Pulse from Jelena Martinovic

May 29, 2024 | 1:34 pm

Vext Science, Inc. reported a slight decrease in 2023 revenue to $34.8 million from $35.4 million in 2022, with a year-over-year increase in Q4 revenue. The company anticipates growth in Ohio's cannabis market in 2024. Net income and adjusted EBITDA for FY 2023 and Q4 2023 also saw declines compared to the previous year. VEXTF shares rose 4.47% after the market close on Thursday.

Portfolio Pulse from Jelena Martinovic

May 10, 2024 | 1:31 pm

Cannabis industry valuations and multiples for major MSOs have increased Y/O/Y, driven by rescheduling prospects. The EV/NTM EBITDA multiples for 14 MSOs showed an aggregate 39% increase, with notable exceptions like Jushi, TerrAscend, and Ascend experiencing declines. Factors influencing these changes include variations in enterprise value and EBITDA estimates, with a general trend towards valuing EBITDA at higher multiples despite a decrease in EBITDA estimates for some. Companies like Cresco and Ascend, showing modest valuation multiples but increased EBITDA expectations, may warrant further investigation.

Portfolio Pulse from Viridian Capital Advisors

April 18, 2024 | 4:19 pm

The cannabis industry is experiencing significant growth with new store openings and consumption lounges across the U.S. Florida's Supreme Court approved a recreational cannabis legalization initiative, leading to new dispensaries by Cansortium Inc. and Trulieve Cannabis Corp. Michigan, California, Nevada, New Jersey, New York, and Texas also saw new cannabis retail developments. Notably, Planet 13 Holdings Inc. opened Nevada's second state-approved consumption lounge. The Benzinga Cannabis Capital Conference in Florida highlights the industry's expansion and future prospects.

Portfolio Pulse from Jelena Martinovic

April 09, 2024 | 3:38 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.